• BioForce Nanosciences filed a Form 12b-25 to delay its quarterly report on Form 10-Q for period ended March 31, 2026.
• Filing was not completed by deadline due to difficulty compiling required financial and other information without unreasonable effort or expense.
• Company expects to file Form 10-Q within 5 calendar days of original due date under Rule 12b-25 extension.
• Notification indicated no anticipated significant change in results of operations versus corresponding prior-year period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioForce Nanosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001091818-26-000070), on May 13, 2026, and is solely responsible for the information contained therein.